Achieve Life Sciences Inc (ACHV) Stock Price, Quote & News

Latest News on ACHV

Jan 10, 2025, 8:30 AM EST - 7 days ago

Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

Jan 7, 2025, 8:30 AM EST - 10 days ago

Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission

Jan 6, 2025, 8:30 AM EST - 11 days ago

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

Dec 9, 2024, 8:30 AM EST - 5 weeks ago

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Dec 3, 2024, 8:30 AM EST - 6 weeks ago

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

Nov 25, 2024, 7:54 AM EST - 7 weeks ago

Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma)

Nov 14, 2024, 8:30 AM EST - 2 months ago

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Nov 9, 2024, 7:32 AM EST - 2 months ago

Achieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call Transcript

Oct 23, 2024, 8:00 AM EDT - 3 months ago

Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting

Oct 16, 2024, 8:00 AM EDT - 3 months ago

Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline

Oct 1, 2024, 8:45 AM EDT - 3 months ago

Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs

Aug 26, 2024, 4:30 PM EDT - 5 months ago

Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors

Aug 14, 2024, 4:58 AM EDT - 5 months ago

Achieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:01 PM EDT - 5 months ago

Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update

Jul 31, 2024, 8:00 AM EDT - 6 months ago

Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence

Jul 29, 2024, 8:00 AM EDT - 6 months ago

Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank

Jul 25, 2024, 8:00 AM EDT - 6 months ago

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024

Jul 9, 2024, 8:00 AM EDT - 6 months ago

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

Jul 1, 2024, 1:46 PM EDT - 7 months ago

Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement

May 17, 2024, 8:00 AM EDT - 8 months ago

Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

May 9, 2024, 7:58 PM EDT - 9 months ago

Achieve Life Sciences, Inc. (ACHV) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:01 PM EDT - 9 months ago

Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update

May 6, 2024, 11:16 AM EDT - 9 months ago

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

Apr 25, 2024, 8:00 AM EDT - 9 months ago

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

Apr 4, 2024, 6:30 AM EDT - 10 months ago

Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns

Mar 28, 2024, 9:03 PM EDT - 10 months ago

Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 4:01 PM EDT - 10 months ago

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

Feb 29, 2024, 8:01 AM EST - 11 months ago

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission

Feb 29, 2024, 8:00 AM EST - 11 months ago

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

Dec 12, 2023, 8:53 AM EST - 1 year ago

Achieve Life Sciences shares drop as analysts see delayed launch of smoking-cessation treatment

Nov 9, 2023, 8:08 PM EST - 1 year ago

Achieve Life Sciences, Inc. (ACHV) Q3 2023 Earnings Call Transcript

Oct 26, 2023, 8:00 AM EDT - 1 year ago

Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023

Sep 11, 2023, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting

Aug 15, 2023, 10:01 AM EDT - 1 year ago

Achieve Life Sciences, Inc. (ACHV) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 4:00 PM EDT - 1 year ago

Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update

Aug 1, 2023, 8:00 AM EDT - 1 year ago

Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast

Jul 11, 2023, 11:23 AM EDT - 1 year ago

Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)

May 28, 2023, 4:39 AM EDT - 1 year ago

Achieve: Exciting Smoking Cessation Drug Approval Could Come Soon

May 23, 2023, 6:12 AM EDT - 1 year ago

Achieve Life Sciences says confirmatory late-stage trial of its treatment for quitting smoking achieved positive results

May 23, 2023, 6:00 AM EDT - 1 year ago

Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial

May 17, 2023, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank

May 9, 2023, 4:05 PM EDT - 1 year ago

Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update

Apr 26, 2023, 8:00 AM EDT - 1 year ago

Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023

Apr 25, 2023, 4:37 PM EDT - 1 year ago

Achieve: Late-Stage Biotech Developing Vaping And Smoking Cessation Drugs

Apr 14, 2023, 8:00 AM EDT - 1 year ago

Achieve Life Sciences to Present at Life Science Innovation Northwest 2023 Conference

Mar 30, 2023, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Announces Refresh to Board of Directors

Mar 17, 2023, 8:00 AM EDT - 2 years ago

Achieve Life Sciences Announces Granting of New Hire Inducement Award

Mar 16, 2023, 9:33 PM EDT - 2 years ago

Achieve Life Sciences, Inc. (ACHV) Q4 2022 Earnings Call Transcript

Mar 16, 2023, 4:05 PM EDT - 2 years ago

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update

Mar 8, 2023, 8:00 AM EST - 2 years ago

Market Cap	105.58M
Revenue (ttm)	0.00
Net Income (ttm)	-29.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	379,900
Avg Vol	190,156
Day's Range	N/A - N/A
Shares Out	34.39M
Stochastic %K	8%
Beta	1.66
Analysts	Strong Sell
Price Target	$16.29